Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 3 pages · Chinese
Release
Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on 6ix
Earlier from Zhejiang Shapuaisi Pharmaceutical
- Announcement on Proposed Termination of Acquisition of 100% Equity in Shanghai Qinli Industrial Co., Ltd. and Related Party Transactions
- Report for Q1 2026
- Indicative Announcement on Convening the 2025 Annual General Meeting
- Announcement on Postponing Reply to Letter of Inquiry from SSE
- Announcement on the Remuneration Plan for Directors and Senior Management Members in 2026
Later from Zhejiang Shapuaisi Pharmaceutical
- Announcement on Obtaining Drug Registration Certificate for Sildenafil Citrate Orally Disintegrating Tablets
- Announcement on Release of Pledge of Shares by Actual Controller
- Announcement on Obtaining the "Drug Registration Certificate" for Vitamin B12 Eye Drops
- Announcement on Resolutions of the 16th Meeting of the 6th Board of Directors
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow Zhejiang Shapuaisi Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shapuaisi Pharmaceutical